Differential Changes In Cortical Tumour Necrosis Factor Signalling In Mood Disorders And Schizophrenia
Funder
National Health and Medical Research Council
Funding Amount
$642,078.00
Summary
Changes in inflammation-related pathways contribute to the symptoms of psychiatric disorders and tumour necrosis factor ? (TNF) is a protein central to regulating theses pathways. We have now shown that changes in pathways regulated by TNF are present in the brains of people with schizophrenia and mood disorders. This means that the symptoms experienced by those with the different disorders may be linked to differential changes in TNF-regulated pathways in the brain.
Brain Connectivity Imaging Markers To Confirm Diagnosis For Bipolar Vs. Unipolar Depression – A Connectome Approach.
Funder
National Health and Medical Research Council
Funding Amount
$434,369.00
Summary
Differentiating Bipolar disorders from Unipolar Depression is a major clinical challenge. This misdiagnosis hinders optimal clinical care and has many deleterious consequences such self-harm, increased chances of suicide, poor prognosis, and greater health care costs related to this disorder. This project will provide urgently-needed advance in accurate identification of Bipolar disorders using Magnetic Resonance Imaging and remove one of the key obstacles to accurate diagnosis.
It is widely accepted that just under half of all people with bipolar disorder have a chronic physical illness. The one neglected comorbidity is osteoporosis. In this project, the association between bipolar disorder and bone fragility will be examined. Additionally, a potential common mechanism, systemic inflammation, which may underlie both diseases, will be investigated as a potential mediator of the relationship.
Leveraging Record Linkage For Single-indication Medications To Boost Recruitment In Psychiatric And Pharmaco- Genetics
Funder
National Health and Medical Research Council
Funding Amount
$1,840,595.00
Summary
Genome-wide association studies (GWAS) have shown that psychiatric disorders are highly polygenic and that increasing the power of these analyses by increasing the number of participants does lead to the identification of new treatment targets and biomarkers. We seek funding to greatly boost the power of GWAS for Schizophrenia and Bipolar Disorder by using prescription records to recruit individuals who have been prescribed medications that are only used to treat these conditions.
Randomised Controlled Trial Of The RECOVER Tailored Psychological Intervention For First Episode Bipolar Disorder
Funder
National Health and Medical Research Council
Funding Amount
$1,550,291.00
Summary
Bipolar disorder (BD) is one of the most disabling health conditions experienced by young adults, yet there are currently no psychological treatment options specifically developed for early intervention in BD. This project will test if a new psychological intervention called RECOVER, administered to young people who have experienced a first episode of BD, can help prevent this experience from developing into a chronic disorder.
Unravelling The Genetic Causes Of Bipolar Disorder: Lessons From Rare But Highly Penetrant Variants In Very Heritable Forms Of Illness
Funder
National Health and Medical Research Council
Funding Amount
$705,834.00
Summary
Bipolar disorder is a severe mood disorder affecting over 350,000 Australians, for which the causes remain largely unknown. This project will apply a powerful new technology, exome sequencing, to rare families with highly heritable forms of bipolar disorder to identify specific genetic factors which increase disease risk. A greater understanding of the genetic causes of this illness may eventually lead to improvements in diagnosis, treatment and quality of life of people suffering with this debi ....Bipolar disorder is a severe mood disorder affecting over 350,000 Australians, for which the causes remain largely unknown. This project will apply a powerful new technology, exome sequencing, to rare families with highly heritable forms of bipolar disorder to identify specific genetic factors which increase disease risk. A greater understanding of the genetic causes of this illness may eventually lead to improvements in diagnosis, treatment and quality of life of people suffering with this debilitating mental illness.Read moreRead less
Gene Expression Signature Technology To Repurpose Drugs For Bipolar Disorder
Funder
National Health and Medical Research Council
Funding Amount
$482,800.00
Summary
In this project we will generate a Gene Expression Signature that best characterises the overall biological effects of a cocktail of drugs currently used to treat bipolar disorder. The Signature will be identified in cells and intact brains, and then validated using human gene expression profiling. The validated Signature will then be used to screen libraries and discover new drugs for treating bipolar disorder.
The Biology Of Risk For Bipolar Disorder: Genetic Effects In A High-risk Longitudinal Study
Funder
National Health and Medical Research Council
Funding Amount
$856,412.00
Summary
Bipolar disorder is a severe mood disorder affecting over 350,000 Australians. Some children of bipolar disorder patients will also become ill, although currently we have no tools to predict which of these genetically at-risk young individuals will eventually develop symptoms. This study will use genetic information plus brain structural changes to predict which at-risk individuals are likely to become ill. This study will help elucidate early clinical and biological markers of bipolar disorder.
Improving Quality Of Life In Late Stage Bipolar Disorder: RCT Of A Novel Psychological Treatment
Funder
National Health and Medical Research Council
Funding Amount
$1,083,620.00
Summary
Hundreds of thousands of Australians have bipolar disorder and receive minimal benefit from existing drug and psychological treatments. ORBIT 2.0 is a new low-intensity online treatment using mindfulness strategies to improve quality of life in this poorly served ‘late stage’ group. Pilot testing suggests ORBIT is effective. This project will refine the intervention and is expected to confirm its clinical and cost effectiveness prior to international roll-out.
P2X7 Receptor And Inflammation In The Pathophysiology Of Mood Disorders
Funder
National Health and Medical Research Council
Funding Amount
$598,063.00
Summary
Mood disorders are chronic disabling mental illnesses affecting a significant proportion of the population. Inherited variations in a particular gene involved in inflammation will be investigated in individuals with mood disorders. This work aims to understand the relationship between inflammation of parts of the brain and mood disorders leading to the potential development of a new therapeutic target.